1 active not recruiting, 1 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow BGM1812: new trials by email Literature Review of BGM1812 trials Research Report on BGM1812
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants BGM1812, Placebo - Overweight or Obesity | Phase 1 | Completed | BrightGene Bio-Medical Technology Co., Ltd. | 60 | 2025-12-05 | 2026-10-15 |
| Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women BGM1812, Placebo - Healhty, Overweight or Obesity | Phase 1 | Active not recruiting | BrightGene Bio-Medical Technology Co., Ltd. | 60 | 2025-10-09 | 2026-10-19 |
Obesity (2) · Overweight (2)
BrightGene Bio-Medical Technology Co., Ltd. (2)
China (1) · United States (1)